The Myorelaxing Agents Market is projected to grow from USD 1,203.2 million in 2025 to USD 3,005.6 million by 2035, at a CAGR of 9.6%. Botox-like peptides will dominate with a 49.1% market share, while encapsulated delivery systems will lead with a 52.2% share in 2025.